Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Current Assets (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Current Assets readings, the most recent being $1544.0 for Q1 2026.

  • On a quarterly basis, Current Assets fell 59.22% to $1544.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $1544.0, a 59.22% decrease, with the full-year FY2025 number at $29085.0, up 35.33% from a year prior.
  • Current Assets reached $1544.0 in Q1 2026 per CBIH's latest filing, down from $22131.0 in the prior quarter.
  • The five-year high for Current Assets was $29085.0 in Q2 2025, with the low at $1544.0 in Q1 2026.
  • A 4-year average of $17161.5 and a median of $18942.0 in 2025 define the central range for Current Assets.
  • Peak annual rise in Current Assets hit 43.53% in 2025, while the deepest fall reached 79.46% in 2025.
  • Year by year, Current Assets stood at $19739.0 in 2023, then decreased by 21.89% to $15419.0 in 2024, then skyrocketed by 43.53% to $22131.0 in 2025, then crashed by 93.02% to $1544.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Current Assets are $1544.0 (Q1 2026), $22131.0 (Q4 2025), and $18942.0 (Q3 2025).